Aytu Biopharma (NasdaqCM:AYTU) Q4 2025 Earnings Call September 23, 2025 04:30 PM ET Company ParticipantsRyan Selhorn - CFOJosh Disbrow - Co-founder, CEO, and DirectorRobert Blum - Managing DirectorConference Call ParticipantsNaz Rahman - VP and Biopharmaceuticals Equity Research AnalystEd Woo - Senior Research AnalystThomas Flaten - Senior Research AnalystOperatorGreetings. Welcome to the Aytu BioPharma to report fiscal 2025 full year and fourth quarter in operational and financial results on September 23, ...